Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
52.43
+0.90 (1.74%)
Nov 21, 2024, 2:19 PM EST - Market open
Viking Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 5,842 | 1,862 | 721 | 360 | 411 | 580 | |
| Market Cap Growth | 533.47% | 158.23% | 100.31% | -12.38% | -29.13% | 6.02% | |
| Enterprise Value | 4,813 | 1,487 | 567 | 144 | 156 | 292 | |
| Last Close Price | 51.53 | 18.61 | 9.40 | 4.60 | 5.63 | 8.02 | |
| PB Ratio | 6.30 | 5.34 | 4.96 | 1.78 | 1.68 | 2.09 | |
| P/TBV Ratio | 7.70 | 5.34 | 4.96 | 1.78 | 1.68 | 2.09 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Quick Ratio | 36.23 | 18.92 | 7.08 | 23.02 | 20.48 | 40.67 | |
| Current Ratio | 36.47 | 19.19 | 7.61 | 23.98 | 21.12 | 41.83 | |
| Return on Equity (ROE) | -15.50% | -34.79% | -39.67% | -24.65% | -15.15% | -8.97% | |
| Return on Assets (ROA) | -12.68% | -23.47% | -23.19% | -14.90% | -9.86% | -6.97% | |
| Return on Capital (ROIC) | -13.06% | -25.38% | -25.21% | -15.58% | -10.21% | -7.10% | |
| Earnings Yield | -1.73% | -4.61% | -9.55% | -15.28% | -9.62% | -4.45% | |
| FCF Yield | -1.29% | -3.94% | -6.71% | -13.22% | -5.30% | -4.27% | |
| Buyback Yield / Dilution | -19.97% | -22.79% | 0.47% | -6.34% | -0.89% | -24.97% | |
| Total Shareholder Return | -19.97% | -22.79% | 0.47% | -6.34% | -0.89% | -24.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.